Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127373381 | 12737338 | 1 | I | 20160829 | 20160912 | 20160912 | EXP | TW-B. BRAUN MEDICAL INC.-1057250 | B BRAUN | CHEN-HUI CHONG, GUAN-MIN LAI, JEN-TSUN LIN, CENTRAL PONTINE MYELINOLYSIS (CPM) AND EXTRAPONTINE MYELINOLYSIS (EPM) FOLLOWING CONCURRENT CHEMORADIOTHERAPY FOR NASOPHARYNGEAL CARCINOMA, JOURNAL OF CANCER RESEARCH AND PRACTICE, VOLUME 3, ISSUE 2, JUNE 2016, PAGES 58-62. | 50.00 | YR | F | Y | 0.00000 | 20160912 | OT | TW | TW |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 127373381 | 12737338 | 1 | PS | SODIUM CHLORIDE. | SODIUM CHLORIDE | 1 | 19635 | ||||||||||||
| 127373381 | 12737338 | 2 | C | DOCETAXEL. | DOCETAXEL | 1 | 0 | 60 | MG/M**2 | ||||||||||
| 127373381 | 12737338 | 3 | C | CISPLATIN. | CISPLATIN | 1 | 0 | 80 | MG/M**2 | ||||||||||
| 127373381 | 12737338 | 4 | C | FLUOROURACIL. | FLUOROURACIL | 1 | 0 | 800 | MG/M**2 | ||||||||||
| 127373381 | 12737338 | 5 | C | PIPERACILLIN, TAZOBACTAM | PIPERACILLIN SODIUMTAZOBACTAM SODIUM | 1 | 0 | 3375 | MG | ||||||||||
| 127373381 | 12737338 | 6 | C | POTASSIUM CHLORIDE. | POTASSIUM CHLORIDE | 1 | 0 | 60 | MEQ | ||||||||||
| 127373381 | 12737338 | 7 | C | AMPHOTERICIN B. | AMPHOTERICIN B | 1 | 0 | ||||||||||||
| 127373381 | 12737338 | 8 | C | Parenteral nutrition supplement | 2 | 0 | |||||||||||||
| 127373381 | 12737338 | 9 | C | 3% Sodium Chloride | SODIUM CHLORIDE | 1 | 0 | ||||||||||||
| 127373381 | 12737338 | 10 | C | 0.9% SODIUM CHLORIDE | SODIUM CHLORIDE | 1 | 0 |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 127373381 | 12737338 | 1 | Hyponatraemia |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 127373381 | 12737338 | OT |
| 127373381 | 12737338 | HO |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 127373381 | 12737338 | Osmotic demyelination syndrome |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |